Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized...
Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
•Co-micronized palmitoylethanolamide/polydatin (PEA/PD) demonstrated efficacy in pediatric irritable bowel syndrome (IBS), significantly increasing complete remission.•Subgroup analysis highlighted benefits in the irritable bowel syndrome-diarrhea subtype.•Treatment with PEA/PD resulted in a notable reduction in abdominal pain intensity and frequen...
Alternative Titles
Full title
Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2957164272
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2957164272
Other Identifiers
ISSN
0899-9007
E-ISSN
1873-1244
DOI
10.1016/j.nut.2024.112397
